Niels C.
- Country
- The Netherlands
- Department
- Pulmonology
Research Overview
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
- A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)
- Phase 3 Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancer Post-PD-1/PD-L1 Inhibitor Progression
Data & Insights
Has run more than one trial at 154 of 364 partner sites.
Specializations
Non-Small Cell Lung Cancer Treatment
The investigator specializes in treating various stages of non-small cell lung cancer (NSCLC), with particular focus on advanced and metastatic cases. Their research encompasses both early-stage and advanced disease management.
- Resectable NSCLC Treatment
- Advanced and Metastatic NSCLC
- KRAS G12C-Positive NSCLC
Their work includes evaluation of novel therapeutic approaches for locally advanced NSCLC and treatment strategies for unresectable disease.
Small Cell Lung Cancer Expertise
The investigator focuses on developing treatments for small cell lung cancer (SCLC), with particular emphasis on both limited-stage and extensive-stage disease management.
- Limited Disease SCLC Treatment
- Post-Chemoradiotherapy Care
- Extensive-Stage SCLC Management
Their research involves innovative therapeutic approaches including consolidation therapy and combined treatment modalities.
Immunotherapy Applications
The investigator explores various immunotherapeutic approaches in lung cancer treatment, including novel combinations and optimization strategies.
- Combination Immunotherapy
- Checkpoint Inhibitor Therapy
- Immunotherapy Dose Optimization
Their work includes investigation of targeted therapies and their integration with standard treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.